biopharmaceuticals

The Government of Québec announced today a $10 million investment in the Personalized Medicine Partnership for Cancer (PMPC). This public-private partnership will be focused on establishing an integrated approach for the development and implementation of clinical biomarkers and other personalized healthcare solutions to improve the outcome and cost-efficiency of healthcare services provided to cancer patients in the province of Québec and abroad.

Classified as: medicine, Cancer, biopharmaceuticals, healthcare, medication
Category:
Published on: 21 Feb 2013